Vonoprazan-based Therapy

Vonoprazan-Based Therapy is a pharmacological treatment regimen for Helicobacter pylori eradication that employs vonoprazan, a potassium-competitive acid blocker, as the foundational acid-suppressing agent to enhance gastric acid suppression and improve antimicrobial efficacy compared to traditional proton pump inhibitors.

212

Publications

9.9K

Citations

1.2K

Authors

385

Institutions

Publications per year

2017–2026

185

Publications

212

1–5 of 212

Authors

1.2K

  1. AN
    Akira Nishimura

    Takeda (Japan), Japan

    13 publications · 2.4K citations

    13

    h-index

  2. KA
    Kiyoshi Ashida

    Saiseikai Nakatsu Hospital, Japan

    12 publications · 1.6K citations

    12

    h-index

  3. KI
    Katsuhiko Iwakiri

    Nippon Medical School, Japan

    11 publications · 978 citations

    11

    h-index

  4. SS
    Satoshi Shinozaki

    Jichi Medical University, Japan

    6 publications · 155 citations

    8

    h-index

  5. HY
    Hironori Yamamoto

    Jichi Medical University, Japan

    6 publications · 155 citations

    8

    h-index

1–5 of 1.2K

Venues

  1. Helicobacter

    18 publications · 633 citations

    16

    h-index

  2. Digestion

    15 publications · 663 citations

    15

    h-index

  3. Alimentary Pharmacology & Therapeutics

    14 publications · 2K citations

    14

    h-index

  4. Internal Medicine

    10 publications · 263 citations

    11

    h-index

  5. Journal of Gastroenterology

    9 publications · 316 citations

    10

    h-index

1–5